Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Skin Problems & Treatments Health Center

Font Size

FDA Approves New Impetigo Treatment

Ointment Called Altabax Treats Children and Adults With the Skin Infection
WebMD Health News
Reviewed by Louise Chang, MD

April 13, 2007 -- The FDA today approved a new prescription antibacterial ointment called Altabax to treat impetigo.

Impetigo is a highly contagious skin infection caused by bacteria. It's most common among children and is usually spread through physical contact with someone who has impetigo, or from sharing clothes, bedding, towels, or other objects.

Altabax is for patients who are at least 9 months old and have impetigo due to the common bacteria Staphylococcus aureus or Streptococcus pyogenes, states GlaxoSmithKline, which makes Altabax.

Altabax represents the first new class of prescription topical antibacterials to be approved by the FDA in nearly 20 years, notes GlaxoSmithKline.

Altabax is used twice daily for five days. Other prescription topical antibiotics are used as much as three times daily for up to 12 days, says GlaxoSmithKline.

Altabax Approval

The FDA approved Altabax based on effectiveness data from a study of 210 adults and children with impetigo.

A total of 139 patients received Altabax. The others patients got an ointment containing no medicine (placebo).

After five days of treatment, success was more common in the Altabax group than in the placebo group, according to GlaxoSmithKline.

The FDA says it also reviewed safety data on approximately 2,000 Altabax-treated adults and children who were at least 9 months old and another 1,000 patients who used other antibiotics or a placebo.

The most common Altabax-related adverse event was irritation at the application site. That problem affected less than 2% of the patients, notes the FDA.

Today on WebMD

Pictures and symptoms of the red, scaly rash.
woman with dyed dark hair
What it says about your health.
woman with cleaning products
Top causes of the itch that rashes.
atopic dermatitus
Identify and treat common skin problems.
itchy skin
shingles rash on skin
woman with skin tag
Woman washing face
woman washing her hair in sink
close up of womans bare neck
woman with face cream